Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022
For the nine months, net income was USD 0.835772 million compared to net loss of USD 1.99 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.07 a year ago.